\
&
Contact us
\
&
Contact us
Published on | 11 months ago
Programmes COSTThe COST Open call OC-2025-1 is now open for submission and will close on 21 October 2025 at 12h00 (noon) CEST.
More information on the Open Call can be found here.
Please note that for the 2025 Open Call a new version of the Technical Annex has been introduced. Be aware to use and upload the new and correct version of the Technical Annex when submitting your application.
A new and revised Guidelines for Proposers is also available. The changes in the Proposers’ Guidelines are the following:
For further queries on the COST Open Call don’t hesitate to get in touch with us via cost@fwo.be.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
